CLINICAL_TRIALS
trial_result
· 2022-05-27
Clinical Trial Update: Study of Ataluren in Participants With Nonsense Mutation Aniridia [Phase 2]
Summary
Phase 2 clinical trial of ataluren in participants with nonsense mutation-associated aniridia has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PTC Therapeutics | Conditions: Aniridia | Phase 2 | Status: COMPLETED | Results posted: 2022-05-27